A detailed history of Prudential Financial Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Prudential Financial Inc holds 210,233 shares of VRTX stock, worth $85.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
210,233
Previous 289,642 27.42%
Holding current value
$85.8 Million
Previous $136 Million 27.98%
% of portfolio
0.14%
Previous 0.21%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $36.5 Million - $40.2 Million
-79,409 Reduced 27.42%
210,233 $97.8 Million
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $13.4 Million - $16.6 Million
34,181 Added 13.38%
289,642 $136 Million
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $1.89 Million - $2.07 Million
4,642 Added 1.85%
255,461 $107 Million
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $18.2 Million - $21.8 Million
-53,122 Reduced 17.48%
250,819 $102 Million
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $57.7 Million - $61.8 Million
-170,512 Reduced 35.94%
303,941 $106 Million
Q2 2023

Aug 11, 2023

SELL
$314.42 - $351.91 $18.7 Million - $20.9 Million
-59,395 Reduced 11.13%
474,453 $167 Million
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $41.5 Million - $47.4 Million
-146,638 Reduced 21.55%
533,848 $168 Million
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $11 Million - $12.4 Million
-38,436 Reduced 5.35%
680,486 $0
Q3 2022

Nov 04, 2022

BUY
$273.83 - $305.53 $3.64 Million - $4.06 Million
13,296 Added 1.88%
718,922 $208 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $10.2 Million - $12.6 Million
-43,229 Reduced 5.77%
705,626 $199 Million
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $19.6 Million - $23.1 Million
88,350 Added 13.38%
748,855 $195 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $8.8 Million - $11.1 Million
49,727 Added 8.14%
660,505 $145 Million
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $32.1 Million - $35.9 Million
177,000 Added 40.8%
610,778 $114 Million
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $26.4 Million - $31.1 Million
140,680 Added 48.0%
433,778 $87.5 Million
Q1 2021

May 12, 2021

SELL
$207.02 - $241.31 $41 Million - $47.8 Million
-198,252 Reduced 40.35%
293,098 $63 Million
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $101 Million - $134 Million
485,893 Added 8904.03%
491,350 $116 Million
Q3 2020

Aug 05, 2021

SELL
$255.65 - $303.1 $127 Million - $151 Million
-497,968 Reduced 98.92%
5,457 $1.49 Million
Q3 2020

Nov 16, 2020

BUY
$255.65 - $303.1 $128 Million - $152 Million
500,018 Added 14676.2%
503,425 $137 Million
Q2 2020

Aug 05, 2021

SELL
$225.48 - $295.8 $161 Million - $211 Million
-712,573 Reduced 99.52%
3,407 $989,000
Q2 2020

Aug 12, 2020

BUY
$225.48 - $295.8 $161 Million - $211 Million
713,459 Added 28300.63%
715,980 $208 Million
Q1 2020

Aug 05, 2021

SELL
$199.77 - $247.81 $148 Million - $184 Million
-742,838 Reduced 99.66%
2,521 $600,000
Q1 2020

May 12, 2020

BUY
$199.77 - $247.81 $148 Million - $184 Million
743,350 Added 37001.0%
745,359 $177 Million
Q4 2019

Aug 05, 2021

SELL
$166.71 - $223.91 $103 Million - $138 Million
-617,636 Reduced 99.68%
2,009 $440,000
Q4 2019

Feb 11, 2020

BUY
$166.71 - $223.91 $103 Million - $138 Million
618,471 Added 52680.66%
619,645 $136 Million
Q3 2019

Aug 05, 2021

SELL
$166.23 - $187.09 $115 Million - $130 Million
-694,786 Reduced 99.83%
1,174 $199,000
Q3 2019

Nov 13, 2019

BUY
$166.23 - $187.09 $116 Million - $130 Million
695,284 Added 102852.66%
695,960 $118 Million
Q2 2019

Aug 05, 2021

SELL
$164.61 - $190.37 $105 Million - $121 Million
-635,344 Reduced 99.89%
676 $124,000
Q2 2019

Aug 08, 2019

BUY
$164.61 - $190.37 $105 Million - $121 Million
635,590 Added 147811.62%
636,020 $0
Q1 2019

Aug 05, 2021

SELL
$163.73 - $194.7 $85.8 Million - $102 Million
-524,269 Reduced 99.92%
430 $79,000
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $85.9 Million - $102 Million
524,458 Added 217617.44%
524,699 $0
Q4 2018

Aug 05, 2021

SELL
$151.91 - $192.21 $49.8 Million - $63 Million
-327,886 Reduced 99.93%
241 $40,000
Q4 2018

Feb 07, 2019

BUY
$151.91 - $192.21 $49.8 Million - $63 Million
327,975 Added 215773.03%
328,127 $54.4 Million
Q3 2018

Sep 01, 2021

SELL
$167.73 - $192.74 $152 Million - $174 Million
-905,223 Reduced 99.98%
152 $29,000
Q3 2018

Nov 07, 2018

BUY
$167.73 - $192.74 $152 Million - $174 Million
905,270 Added 862161.88%
905,375 $0
Q2 2018

Sep 01, 2021

SELL
$145.72 - $169.96 $45.4 Million - $53 Million
-311,650 Reduced 99.97%
105 $18,000
Q2 2018

Aug 13, 2018

BUY
$145.72 - $169.96 $4.73 Million - $5.51 Million
32,430 Added 11.61%
311,755 $0
Q1 2018

May 04, 2018

SELL
$151.6 - $177.13 $10.3 Million - $12 Million
-67,930 Reduced 19.56%
279,325 $0
Q4 2017

Feb 13, 2018

BUY
$137.28 - $155.55 $91,977 - $104,218
670 Added 0.19%
347,255 $52 Million
Q3 2017

Nov 02, 2017

BUY
$148.13 - $162.24 $51.3 Million - $56.2 Million
346,585
346,585 $52.7 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.